|
US7750007B2
(en)
*
|
2006-11-06 |
2010-07-06 |
Supergen, Inc. |
Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
AR067326A1
(es)
*
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
CA2696631A1
(en)
*
|
2007-08-17 |
2009-02-26 |
Icagen, Inc. |
Heterocycles as potassium channel modulators
|
|
US8431608B2
(en)
|
2007-08-17 |
2013-04-30 |
Icagen Inc. |
Heterocycles as potassium channel modulators
|
|
PE20091468A1
(es)
|
2008-02-28 |
2009-10-22 |
Novartis Ag |
DERIVADOS DE 3-METIL-IMIDAZO-[1,2-b]-PIRIDAZINA
|
|
US20110105457A1
(en)
*
|
2008-04-18 |
2011-05-05 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on pi3k
|
|
US20110071052A1
(en)
*
|
2008-04-25 |
2011-03-24 |
Maria Helena Hilhorst |
Measurement of protein kinase activity in cerebrospinal fluid for diagnosis of neurological and psychiatric disorders
|
|
CA2722418C
(en)
*
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
WO2010062829A1
(en)
*
|
2008-11-28 |
2010-06-03 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for treating osteoporosis
|
|
PA8851101A1
(es)
|
2008-12-16 |
2010-07-27 |
Lilly Co Eli |
Compuesto amino pirazol
|
|
AU2010231162B2
(en)
|
2009-04-02 |
2014-12-11 |
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
|
|
EP2243481A1
(en)
*
|
2009-04-24 |
2010-10-27 |
PamGene B.V. |
Irak kinase family as novel drug target for Alzheimer
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
PH12012500778A1
(en)
|
2009-10-30 |
2012-11-26 |
Janssen Pharmaceutica Nv |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
WO2011137155A1
(en)
|
2010-04-28 |
2011-11-03 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
JP2013542259A
(ja)
|
2010-11-12 |
2013-11-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
置換アザインダゾール化合物
|
|
RU2632900C2
(ru)
*
|
2010-11-19 |
2017-10-11 |
Лиганд Фармасьютикалс Инкорпорейтед |
Гетероциклические амины и их применение
|
|
EP2463289A1
(en)
*
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
|
CA2836203A1
(en)
*
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
|
CA2837630A1
(en)
|
2011-06-01 |
2012-12-06 |
Knut Eis |
Substituted aminoimidazopyridazines
|
|
EP2723748B1
(en)
|
2011-06-22 |
2016-10-12 |
Bayer Intellectual Property GmbH |
Heterocyclyl aminoimidazopyridazines
|
|
JP6115962B2
(ja)
|
2011-06-27 |
2017-04-19 |
ヤンセン ファーマシューティカ エヌ．ベー． |
１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体
|
|
DK2734205T3
(en)
|
2011-07-21 |
2018-06-14 |
Tolero Pharmaceuticals Inc |
Heterocyclic Protein Kinase Inhibitors
|
|
UA117092C2
(uk)
*
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Амінозаміщені імідазопіридазини
|
|
US9320737B2
(en)
|
2011-09-23 |
2016-04-26 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
|
WO2013049263A1
(en)
|
2011-09-27 |
2013-04-04 |
Bristol-Myers Squibb Company |
Substituted bicyclic heteroaryl compounds
|
|
EP2773207B1
(en)
*
|
2011-10-31 |
2018-03-07 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
US9643974B2
(en)
|
2011-12-12 |
2017-05-09 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
|
ES2686500T3
(es)
*
|
2012-01-13 |
2018-10-18 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con heterocíclicos, útiles como inhibidores de cinasas
|
|
RU2014140739A
(ru)
*
|
2012-03-09 |
2016-04-27 |
Лексикон Фармасьютикалз, Инк. |
Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения
|
|
WO2013144189A1
(en)
|
2012-03-29 |
2013-10-03 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
|
EP2834245B1
(en)
|
2012-04-04 |
2017-12-13 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazopyridazines
|
|
WO2014001314A1
(en)
|
2012-06-26 |
2014-01-03 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
AU2013289284B2
(en)
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
|
PL400213A1
(pl)
|
2012-08-01 |
2014-02-03 |
Celon Pharma Spólka Z Ograniczona Odpowiedzialnoscia |
Pochodne imidazo[1,2-b]pirydazyno-6-aminy jako inhibitory kinazy JAK-2
|
|
RU2702908C2
(ru)
|
2012-11-01 |
2019-10-14 |
Инфинити Фармасьютикалз, Инк. |
Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
|
|
LT2925757T
(lt)
|
2012-11-19 |
2017-12-27 |
Novartis Ag |
Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
|
|
ES2646916T3
(es)
|
2012-11-19 |
2017-12-18 |
Bayer Pharma Aktiengesellschaft |
Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
|
|
JP2016506943A
(ja)
|
2013-01-30 |
2016-03-07 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
Ｍｋｎｋ−１キナーゼ阻害剤としてのアミドイミダゾピリダジン類
|
|
EP2958920A1
(en)
|
2013-02-20 |
2015-12-30 |
Bayer Pharma Aktiengesellschaft |
Substituted-imidazo[1,2-b]pyridazines as mknk1 inhibitors
|
|
CN105431148A
(zh)
|
2013-03-07 |
2016-03-23 |
加利菲亚生物公司 |
混合谱系激酶抑制剂及治疗方法
|
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
KR20160013204A
(ko)
|
2013-05-30 |
2016-02-03 |
인피니티 파마슈티칼스, 인코포레이티드 |
Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
|
|
AR097543A1
(es)
*
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
ES2702126T3
(es)
*
|
2013-12-10 |
2019-02-27 |
Bristol Myers Squibb Co |
Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa
|
|
WO2015104254A1
(en)
|
2014-01-09 |
2015-07-16 |
Bayer Pharma Aktiengesellschaft |
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
|
|
HK1231480A1
(zh)
|
2014-01-10 |
2017-12-22 |
Aurigene Discovery Technologies Limited |
作为irak4抑制剂的吲唑化合物
|
|
IL311677B2
(en)
|
2014-01-13 |
2025-06-01 |
Aurigene Oncology Ltd |
Bicyclic heterocyclyl derivatives as irak4 inhibitors
|
|
US9943516B2
(en)
|
2014-09-30 |
2018-04-17 |
Merck Sharp & Dohme Corp. |
Inhibitors of IRAK4 activity
|
|
EP3200788B1
(en)
|
2014-09-30 |
2019-09-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
WO2016053771A1
(en)
*
|
2014-09-30 |
2016-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
WO2016053772A1
(en)
*
|
2014-09-30 |
2016-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
TWI746426B
(zh)
|
2014-11-16 |
2021-11-21 |
美商亞雷生物製藥股份有限公司 |
(S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
|
|
JP6586463B2
(ja)
|
2014-12-19 |
2019-10-02 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ＰＩ３Ｋβ阻害剤としての複素環連結イミダゾピリダジン誘導体
|
|
DK3233862T3
(da)
|
2014-12-19 |
2019-10-07 |
Janssen Pharmaceutica Nv |
Imidazopyridazinderivater som pi3k-beta-inhibitorer
|
|
CN104592121A
(zh)
*
|
2015-02-13 |
2015-05-06 |
佛山市赛维斯医药科技有限公司 |
含酰肼和硝基苯类结构的化合物、其制备方法及用途
|
|
US10807983B2
(en)
|
2015-03-16 |
2020-10-20 |
Ligand Pharmaceuticals, Inc. |
Imidazo-fused heterocycles and uses thereof
|
|
EP3313844B1
(en)
*
|
2015-06-24 |
2020-08-26 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
WO2017004134A1
(en)
*
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
EP3368039A1
(en)
|
2015-10-26 |
2018-09-05 |
The Regents of The University of Colorado, A Body Corporate |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
UA125026C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
РІДКІ КОМПОЗИЦІЇ (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)ПІРОЛІДИН-1-ІЛ)ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІДУ
|
|
UA125025C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
Способи лікування дитячих ракових захворювань
|
|
MX392604B
(es)
|
2016-05-18 |
2025-03-24 |
Array Biopharma Inc |
Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
|
|
US11254667B2
(en)
|
2016-08-17 |
2022-02-22 |
Children's Hospital Medical Center |
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors
|
|
US11542261B2
(en)
|
2016-08-17 |
2023-01-03 |
Children's Hospital Medical Center |
Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors
|
|
CA3032210A1
(en)
|
2016-09-16 |
2018-03-22 |
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) |
Traf 6 inhibitors
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
US11547696B2
(en)
|
2016-10-28 |
2023-01-10 |
Children's Hospital Medical Center |
Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
CN120267671A
(zh)
|
2017-03-31 |
2025-07-08 |
奥锐金肿瘤有限公司 |
用于治疗血液病的化合物和组合物
|
|
CN110785418A
(zh)
*
|
2017-06-21 |
2020-02-11 |
豪夫迈·罗氏有限公司 |
作为irak4调节剂的异二氢吲哚酮衍生物
|
|
EP4410377A3
(en)
|
2017-10-31 |
2024-11-13 |
Curis, Inc. |
Compounds and compositions for treating hematological disorders
|
|
CA3089762A1
(en)
*
|
2018-01-29 |
2019-08-01 |
Merck Patent Gmbh |
Gcn2 inhibitors and uses thereof
|
|
HUE072069T2
(hu)
|
2019-02-12 |
2025-10-28 |
Sumitomo Pharma America Inc |
2-((1R,4R)-4-((3-(3-(trifluormetil)fenil)imidazo[1,2- b]piridazin-6-il)amino)ciklohexil)propán-2-ol sósavas sójának kristályos formája
|
|
CN111226956B
(zh)
*
|
2019-11-26 |
2021-10-26 |
贵州医科大学 |
3,6-二取代咪唑[1,2-b]哒嗪类衍生物在制备抑制植物病原真菌杀菌剂中的应用
|
|
JP7815127B2
(ja)
|
2020-02-19 |
2026-02-17 |
ニューリックス セラピューティクス，インコーポレイテッド |
インターロイキン－１受容体関連キナーゼの二機能性分解剤およびその治療的使用
|
|
WO2021216757A1
(en)
*
|
2020-04-21 |
2021-10-28 |
The Uab Research Foundation |
Rna-binding protein multimerization inhibitors and methods of use thereof
|
|
EP4185279A4
(en)
|
2020-07-24 |
2024-05-01 |
Secura Bio, Inc. |
TREATING CANCER WITH PI3-KINASE ISOFORM MODULATORS
|
|
EP4289847A4
(en)
*
|
2021-02-08 |
2025-01-01 |
Hangzhou Biosun Pharmaceutical Co., Ltd. |
PIM KINASE INHIBITOR
|
|
CA3214747A1
(en)
|
2021-04-08 |
2022-10-13 |
Reinhard Von Roemeling |
Combination therapies for the treatment of cancer
|
|
HUE070709T2
(hu)
|
2021-08-18 |
2025-06-28 |
Nurix Therapeutics Inc |
Interleukin-1 receptorhoz kapcsolódó kinázok kétfunkciós lebontói és terápiás alkalmazásuk
|
|
CN117624166A
(zh)
*
|
2022-08-09 |
2024-03-01 |
苏州朗睿生物医药有限公司 |
一种三氮唑衍生物及其制备方法和用途
|